3. Introduction
3
Catheter ablation standard therapy for AF
Recurrence after pulmonary vein isolation (PVI) is electrical reconnection between PV) and the left atrium
(LA).
Presence of non-PV foci (NPVF) is related to AF recurrence after multiple PVI procedures, as well as to
very late AF recurrence
Impact of NPVF on AF recurrence has not evaluated
Present study used examine NPVF prevalence in the first and second PVI sessions and evaluate the impact
of NPVF on AF recurrence after catheter ablation for LA-PV reconnection
4. Methods
4
Retrospectively analyzed
284 patients with drug-refractory paroxysmal atrial fibrillation (PAF) (232) or persistent
atrial fibrillation (PeAF) (52), who underwent PVI between February 2010 and February
2014 at the Tokyo Metropolitan Hiroo Hospital
Patients were excluded,
PeAF lasting >1 year (61)
Short interval between the first and second procedures ( 2)
Use of amiodarone during the procedure (3 patients)
Followup <1 year
5. Methods
5
A total of 216 patients (172 with PAF and 44 with PeAF lasting <1 year) were included
(76%)
All patients underwent a second electrophysiological study at the 6-month follow-up after the
first procedure, regardless of AF recurrence
Performed PVI and catheter ablation for NPVF in the first and second sessions.
NPVF detected for the first time in the second session were defined as newly developed
NPVF (new-NPVF)
Each patient to either the new-NPVF(+) or new-NPVF(-) group, depending on whether
they developed NPVF between the first and second session
11. Discussion
11
Prevalence of NPVF higher in the second session than in the first
New-NPVF in the second session correlated to AF recurrence after repeated catheter ablation
AF history and AF recurrence after the first session were predictors for patients likely to
develop new-NPVF
Proportion with NPVF was 9.6% in the first session
Proportion with NPVF in second session was lower than in previous reports
Among the patients with AF recurrence after the first session, 19 (33.9%) had new-NPVF,
indicating increased prevalence of NPVF as a trigger for recurrent AF after PVI
NPVF originating from the interatrial septum in 22%
12. Discussion
12
OUTCOME AFTER THE SECOND SESSION
NPVF important risk factor for AF recurrence after second session in patients with PAF
Patients without AF recurrence 6 months after the first session had new-NPVF and AF recurrences after
the second procedure
These patients are prone to develop late recurrence after PVI
Ablation for new-NPVF highly recommended to avoid future recurrences
NPVF in the LA area had a higher recurrence than with NPVF in the SVC or crista terminalis
Patients who show new-NPVF, long follow-up with additional medication needed
13. Discussion
13
PREDICTORS FOR NEW-NPVF.
AF history
NPVF in the first session
Longer AF duration
AF type was not related to new-NPVF
Sex and LA volume were not predictors for new-NPVF
14. Discussion
14
AF TRIGGERS AND ORIGIN
Patients without AF recurrence after the first session had high PV reconnection rate (68.2%,
107 of 157)
New-NPVF independent predictor for AF recurrence after the second session, even when
these foci were ablated. .
15. Study limitations
15
Single-center
Retrospective study.
Follow-up period was short (230 days)
Proportion of patientswith NPVF might be underestimated; indeed, NPVF
Occurrence was lower than that reported in previous studies.
Some patients had AF recurrence due to LA-PV reconnection even after the second session
We did not target NPVF that did not induce AF, which influenced our results
Electrocardiography and 24-h Holter electrocardiographic monitoring every 3 to 6 months after the
procedure is insufficient to detect AF episodes in patients with asymptomatic AFrecurrence
16. Conclusions
16
Higher number of NPVF were detected in the second session of PVI
Distribution of NPVF location and number were also different than during the first session
Occurrence of NPVF developed after the first PVI session was correlated with AF recurrence
after catheter ablation of LA-PV reconnection
Long AF history and AF recurrence after the first session need additional ablation for NPVF
AF triggers, with long-term follow-up
NPVF detection and ablation may represent important therapeutic options to prevent AF
recurrence, especially in patients who require repeated procedures.
19. Introduction
19
HRV capture intervals between consecutive normal heart beats
Reflect cardiac autonomic function
Abnormal HRV independent predictor of sudden cardiac death in CHF
PVCs from 24-h Holter associated with development of heart failure
We hypothesized that abnormal HRV identify participants who are at an increased risk for the
development of CHF
20. Method
20
Noninstitutionalized individuals 65 years of age or older
5,201 participants, recruited from 1989 to 1990.
687 African-American individuals were recruited from 1992 to 1993
Physical examinations, laboratory tests, and questionnaires obtained
Holter recording done at year 2 of the CHS, whereas the African-American had baseline
assessments at year 5, had Holter recordings performed in year 7
21. Exclusion criteria
21
Participants with unusable Holter data (i.e., paced rhythms, atrial fibrillation, wandering
atrial pacemaker, or >20% ectopic beats)
Heart failure at time of Holter monitoring
Those with unknown baseline heart failure status
Patient with missing components of Health ABC score
Participants excluded due to incomplete follow-up data.
22. Outcomes
22
Primary outcome-Incident CHF
Heart failure, MI, and stroke tabulated through regular surveys, clinic visits, and calls
Participants were able to report any changes in their medical care
Incident events explored through medical records including discharge summaries, hospital
face sheets, or using International Classification of Diseases-Ninth
23. Ambulatory ECG monitoring and assessment of HRV
23
Holter tapes were recorded
Holter analyses were reviewed by an investigator
Only beats with uniformly detected onsets were labeled as normal
The longest and shortest true N–N intervals were identified
Time domain, frequency domain, and nonlinear HRV measures were determined
Heart rate turbulence (HRT), a relatively novel measure of heart rate responses to isolated
PVCs, was also calculated
HRT is generally reported as the categorical variables turbulence onset (TO) and turbulence
slope (TS)
TS 3.0 ms/RR was categorized as normal, whereas TO 0% considered normal
24. Results
24
260 participants (19%) developed CHF during follow-up (median 10.5 years)
CHF patient were more likely male, older, and higher body mass index.
CHF patient have higher baseline heart rate and systolic blood pressure, as well as higher
baseline NT-proBNP, creatinine, and fasting glucose levels
More likely to have left ventricular hypertrophy and CAD
Participants who developed CHF had decreased 24-h HRV and circadian HRV
Significant differences seen in very low frequency (VLF) power
25. Results
25
Participants who developed CHF, nonlinear HRV measures that capture the organization of
the heart rate time series were significantly more abnormal, reflecting greater disorganization
in heart rate control
Abnormal HRT slope and onset more prevalent in those developed CHF
Ventricular and atrial ectopy counts significantly higher in the CHF group
24-h mean heart rate not different between with and without incident CHF
26. Subgroup analysis
26
A comparison of Holter-based parameters in the subset of participants with a baseline NT-
proBNP 190 pg/ml (1,000), who did (142, 14.2%) and did not (858, 85.8%) develop CHF can
be seen
Participants who developed CHF in this subcohort had significantly higher Health ABC
scores
27. Discussion
27
Increased ventricular ectopy counts and abnormal HRV measures from 24-h Holter
recordings, including decreased DFA1, decreased CV%, increased ln VLF, and abnormal
HRT onset, added to the predictive power of the Health ABC score to identify asymptomatic
older adults who are at increased risk of developing CHF
The model C-statistic increased from 0.73 to 0.77 when HRV was included.
Low-risk subcohort, as defined by NT-proBNP #190 pg/ml, the Health ABC components
significantly associated with CHF were unchanged, and decreased DFA1 remained
independently associated with incident CHF
28. Result
28
HRV parameters were associated with incident CHF independent of the Health ABC score components
Older adults who have cardiac autonomic dysfunction, as manifested by abnormal HRV, may be
predisposed to the development of CHF
DFA1, first described by Peng et al, measures the randomness of the N-N intervals (i.e., the intervals
between normal heart beats in a time series
Lower value of DFA1 reflect a more disorganized, less predictable sinus rhythm
Lower DFA1 was associated with increased mortality in patients with reduced ejection fraction after MI
29. Result
29
Decreased DFA1 with increased heart failure hospitalizations
Decreased DFA1 a strong risk factor for cardiovascular death
Relationship between DFA1 and incident CHF in asymptomatic older adults
Study confirmed that an increased number of PVCs was associated with an increased risk of
CHF, independent of the Health ABC score components,
30. Study limitations
30
HRV can only be measured in normal sinus rhythm, which exclude those with atrial
fibrillation, wandering atrial pacemaker, excessive ectopy, or an underlying paced rhythm,
excluding individuals who are at the greatest risk of developing CHF
Health ABC score components were obtained 2 years before the Holter recordings in the
African-American cohort, these participants may have had a different Health ABC score at
the time of their 24-h Holter measurements
31. Study limitations
31
we did not correct for multiple comparisons, thereby increasing the risk of type I error.
Full clinical application of these findings would require that 24-h Holter recordings be
analyzed to research standards
32. Conclusions
32
Abnormal HRV significantly and independently associated with incident CHF
When combined with increased PVCs, improved the predictive power of the Health ABC
score
Among low-risk older adults with NTproBNP 190 pg/ml, HRV added to the clinical risk
model.
Identification of asymptomatic older adults with abnormal HRV could potentially help direct
targeted strategies for the primary prevention of heart failure
33. Take home message
33
NPVF detection and ablation may represent important therapeutic options to prevent AF
recurrence, especially in patients who require repeated procedures
Abnormal HRV significantly and independently associated with incident CHF